Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease

BACKGROUND/AIMS: Infliximab (IFX) often loses its therapeutic effect in initial responders with inflammatory bowel disease (IBD) over time. Low serum IFX trough levels (TLs) are linked to poor clinical response and outcomes. Maintenance of optimal therapeutic IFX concentrations is important for sust...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gut Liver
Hlavní autoři: Choi, So Yoon, Kang, Ben, Choe, Yon Ho
Médium: Artigo
Jazyk:Inglês
Vydáno: Editorial Office of Gut and Liver 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743797/
https://ncbi.nlm.nih.gov/pubmed/30970435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18129
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky